Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Genomics was a specialized bioinformatics company that provided advanced genomic analysis and metabolic reconstruction services to the life sciences industry. The company was best known for its ERGO genome analysis suite, a comprehensive platform that integrated genomic, biochemical, and phylogenetic data to model complex cellular pathways. This technology enabled researchers in the pharmaceutical, agricultural, and chemical sectors to identify novel drug targets and optimize microbial strains for industrial production. Founded in 1997 and headquartered in Chicago, the company maintained a significant presence in the field of microbial genomics and comparative analysis. Following its acquisition by the Marmon Group in 2007, the company's core technology assets were eventually transitioned to Folio Biosciences in 2012.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Genomics.